A new breast cancer test could detect women who are less likely to respond to a standard breast cancer treatment—and could help improve treatment for these women by giving them other treatment options earlier.
Nov 1, 2022
0
42
Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength ...
Mar 23, 2012
0
0
Researchers from Northwestern University, Evanston, Illinois, have discovered a new factor in the escalation of seizures: the synthesis, or generation, of estrogens in the brain.
May 10, 2016
0
48
A Phase I trial of endoxifen, an active metabolite of the cancer drug tamoxifen, indicates that the experimental drug is safe, with early evidence for anti-tumor activity, a Mayo Clinic study has found. The findings indicate ...
Dec 12, 2013
0
1
A new risk model uses baseline sociodemographic and financial measures to predict which patients prescribed long-term therapy with aromatase inhibitors for breast cancer are at significantly higher risk of stopping that therapy ...
Dec 6, 2023
0
0
A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, finds that menopausal hormone therapy for breast cancer survivors is not associated with breast cancer reoccurrence, despite ...
Jul 20, 2022
0
8
(HealthDay)—Exercise helps relieve aromatase inhibitor (AI)-induced pain in breast cancer survivors, according to research published online Dec. 1 in the Journal of Clinical Oncology.
Dec 10, 2014
0
0
Research led by Queen Mary University of London's Wolfson Institute of Population Health has found that hormone levels, measured through blood tests, are an important indicator of whether women will benefit from recently ...
Dec 6, 2023
0
14
Adding an aromatase inhibitor to presurgery treatment with docetaxel, carboplatin, trastuzumab (Herceptin), and pertuzumab (Perjeta) did not significantly increase or decrease the percentage of patients with hormone receptor ...
Dec 9, 2016
0
0
A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, including permanent DNA modifications in the patient's ...
Mar 26, 2014
0
0
